BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 25385008)

  • 1. Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.
    Lin SJ; Gagnon-Bartsch JA; Tan IB; Earle S; Ruff L; Pettinger K; Ylstra B; van Grieken N; Rha SY; Chung HC; Lee JS; Cheong JH; Noh SH; Aoyama T; Miyagi Y; Tsuburaya A; Yoshikawa T; Ajani JA; Boussioutas A; Yeoh KG; Yong WP; So J; Lee J; Kang WK; Kim S; Kameda Y; Arai T; Zur Hausen A; Speed TP; Grabsch HI; Tan P
    Gut; 2015 Nov; 64(11):1721-31. PubMed ID: 25385008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer.
    Wu Y; Grabsch H; Ivanova T; Tan IB; Murray J; Ooi CH; Wright AI; West NP; Hutchins GG; Wu J; Lee M; Lee J; Koo JH; Yeoh KG; van Grieken N; Ylstra B; Rha SY; Ajani JA; Cheong JH; Noh SH; Lim KH; Boussioutas A; Lee JS; Tan P
    Gut; 2013 Aug; 62(8):1100-11. PubMed ID: 22735568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
    Li X; Pasche B; Zhang W; Chen K
    JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic alterations and molecular subtypes of gastric cancers in Asians.
    Ye XS; Yu C; Aggarwal A; Reinhard C
    Chin J Cancer; 2016 May; 35():42. PubMed ID: 27160712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population.
    Shan L; Ying J; Lu N
    Diagn Pathol; 2013 May; 8():76. PubMed ID: 23656792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of molecular genetic signatures in the delineation of gastric neoplasia.
    Kidd M; Modlin IM; Mane SM; Camp RL; Eick GN; Latich I; Zikusoka MN
    Cancer; 2006 Apr; 106(7):1480-8. PubMed ID: 16502410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection.
    Chiaravalli AM; Feltri M; Bertolini V; Bagnoli E; Furlan D; Cerutti R; Novario R; Capella C
    Virchows Arch; 2006 Mar; 448(3):344-53. PubMed ID: 16261379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Image Analysis of T-Cell Infiltrates in Resectable Gastric Cancer: Association with Survival and Molecular Subtypes.
    Challoner BR; von Loga K; Woolston A; Griffiths B; Sivamanoharan N; Semiannikova M; Newey A; Barber LJ; Mansfield D; Hewitt LC; Saito Y; Davarzani N; Starling N; Melcher A; Grabsch HI; Gerlinger M
    J Natl Cancer Inst; 2021 Jan; 113(1):88-98. PubMed ID: 32324860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
    Li B; Cui Y; Diehn M; Li R
    JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
    Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
    BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A gene expression profile related to immune dampening in the tumor microenvironment is associated with poor prognosis in gastric adenocarcinoma.
    Pasini FS; Zilberstein B; Snitcovsky I; Roela RA; Mangone FR; Ribeiro U; Nonogaki S; Brito GC; Callegari GD; Cecconello I; Alves VA; Eluf-Neto J; Chammas R; Federico MH
    J Gastroenterol; 2014 Nov; 49(11):1453-66. PubMed ID: 24217965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas.
    Bain GH; Collie-Duguid E; Murray GI; Gilbert FJ; Denison A; McKiddie F; Ahearn T; Fleming I; Leeds J; Phull P; Park K; Nanthakumaran S; Matula KM; Grabsch HI; Tan P; Welch A; Schweiger L; Dahle-Smith A; Urquhart G; Finegan M; Petty RD
    Br J Cancer; 2014 Mar; 110(6):1525-34. PubMed ID: 24569475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APC gene deletions in gastric adenocarcinomas in a Chinese population: a correlation with tumour progression.
    Fang Z; Xiong Y; Li J; Liu L; Zhang W; Zhang C; Wan J
    Clin Transl Oncol; 2012 Jan; 14(1):60-5. PubMed ID: 22262720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients.
    Koh J; Ock CY; Kim JW; Nam SK; Kwak Y; Yun S; Ahn SH; Park DJ; Kim HH; Kim WH; Lee HS
    Oncotarget; 2017 Apr; 8(16):26356-26367. PubMed ID: 28412752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric Adenocarcinoma.
    Yu P; Wang Y; Yu Y; Wang A; Huang L; Zhang Y; Liu W; Wu H; Yao M; Du YA; Cheng X
    Oncologist; 2021 May; 26(5):e756-e768. PubMed ID: 33511732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of L1 methylation and tumor-infiltrating lymphocytes as prognostic marker in advanced gastric cancer.
    Kim Y; Rhee YY; Wen X; Cho NY; Bae JM; Kim WH; Kang GH
    Gastric Cancer; 2020 May; 23(3):464-472. PubMed ID: 31691036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma.
    Zhu Y; Zhao Y; Cao Z; Chen Z; Pan W
    Gene; 2022 Apr; 818():146177. PubMed ID: 35065254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actionable gene-based classification toward precision medicine in gastric cancer.
    Ichikawa H; Nagahashi M; Shimada Y; Hanyu T; Ishikawa T; Kameyama H; Kobayashi T; Sakata J; Yabusaki H; Nakagawa S; Sato N; Hirata Y; Kitagawa Y; Tanahashi T; Yoshida K; Nakanishi R; Oki E; Vuzman D; Lyle S; Takabe K; Ling Y; Okuda S; Akazawa K; Wakai T
    Genome Med; 2017 Oct; 9(1):93. PubMed ID: 29089060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association analysis of ERBB2 amplicon genetic polymorphisms and STARD3 expression with risk of gastric cancer in the Chinese population.
    Qiu Y; Zhang ZY; Du WD; Ye L; Xu S; Zuo XB; Zhou FS; Chen G; Ma XL; Schneider ME; Xia HZ; Zhou Y; Wu JF; Yuan-Hong X; Zhang XJ
    Gene; 2014 Feb; 535(2):225-32. PubMed ID: 24291029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic variation in molecular subtype for gastric adenocarcinoma.
    Liao P; Jia F; Teer JK; Knepper TC; Zhou HH; He YJ; McLeod HL
    Gut; 2019 Jul; 68(7):1340-1341. PubMed ID: 29960981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.